Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ted W. Love currently holds 58,393 shares of Global Blood Therapeutics, Inc. (GBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ted W. Love has been a net seller of GBT stock. They have purchased $2.2M and sold $16.7M worth of shares.
Ted W. Love's most recent insider trade was on Jun 5, 2026, when they sold 4,545 shares at $0.00 per share.
Ted W. Love serves as Executive at Global Blood Therapeutics, Inc. (GBT). They have executed 150 insider transactions totaling $19.0M over their tenure at the company.
Ted W. Love holds the position of Executive at Global Blood Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Ted W. Love has shown a selling trading pattern, with $2.2M in total purchases and $16.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ted W. Love was on Aug 1, 2020, when they sold $1.4M worth of GBT shares. This transaction involved 20,834 shares at $67.48 per share.
Ted W. Love currently owns 58,393 shares of Global Blood Therapeutics, Inc. (GBT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ted W. Love's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ted W. Love has 150 Form 4 filings on record as an insider at Global Blood Therapeutics, Inc..
Set alerts for Ted W. Love and 40,000+ other insiders.